Essilorluxottica 0OMK
News
-
Shares in Ray-Ban Maker EssilorLuxottica Gain as AI Glasses Continue to Shine
-
Ray-Ban Maker EssilorLuxottica's Sales Rise, Buoyed by Smartglasses
-
EssilorLuxottica Should Benefit From Smart-Glasses Push — Market Talk
-
Meta to Launch New Smartglasses Models Equipped With Its Muse AI Agent
-
LVMH Shares Hit Near Six-Year Low as European Luxury Woes Deepen
-
EssilorLuxottica Launches Buyback Program Potentially Valued at $918 Million
-
EssilorLuxottica Founder's Son Steps Down From Management Roles
-
Ray-Ban Maker EssilorLuxottica's Sales Growth Slows Despite Smartglasses Boom — 2nd Update
Trading Information
- Previous Close Price
- €174.85
- Day Range
- €173.95–182.35
- 52-Week Range
- €138.30–369.45
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 458.37M
- Market Cap
- €83.25B
- Volume/Avg
- 484,790 / 251,131
Key Statistics
- Price/Earnings (Normalized)
- 27.88
- Price/Sales
- 2.78
- Dividend Yield (Trailing)
- 2.29%
- Dividend Yield (Forward)
- 2.29%
- Dividend Payment Schedule
- Jun
- Total Yield
- 3.37%
Company Profile
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest competitor and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 45% in North America, and the rest in Asia and Latin America.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Value
- Total Number of Employees
- 213,909
- Website
- https://www.essilorluxottica.com
Competitors
Valuation
|
Metric
|
0OMK
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 27.88 | 13.27 |
Price/Book Value | 2.05 | 1.40 |
Price/Sales | 2.78 | 2.83 |
Price/Cash Flow | 13.55 | 12.65 |
Price/Earnings
0OMK
COO
Financial Strength
|
Metric
|
0OMK
|
COO
|
|---|---|---|
Quick Ratio | 0.50 | 0.51 |
Current Ratio | 0.89 | 1.22 |
Interest Coverage | 10.54 | 6.18 |
Quick Ratio
0OMK
COO
Profitability
|
Metric
|
0OMK
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 5.15% | 7.25% |
Return on Equity (Normalized) | 8.49% | 10.89% |
Return on Invested Capital (Normalized) | 6.46% | 9.02% |
Return on Assets
0OMK
COO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|>^SVTx<L | LOCK|!c | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|s>C | LOCK|@j?^F | $53B | |||
| ResMed Inc
RMD
| LOCK|KJl@V<J< | LOCK|J@$v | $36B | |||
| Alcon Inc
ALC
| LOCK|WW><f# | LOCK|?vpWM | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|Vn#PH! | LOCK|h$Cby | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|p@W#SR!> | LOCK|tV | $28B | |||
| Solventum Corp
SOLV
| LOCK|&wQ?@w$ | LOCK|d%S | $15B | |||
| Baxter International Inc
BAX
| LOCK|@^ | LOCK|#m<T | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|R>zfR<@ | LOCK|c^VPr | $12B | |||
| Repligen Corp
RGEN
| LOCK|<^?l%X% | LOCK|@Tg#P | $11B |
United States